血漿分画の世界市場レポート、歴史と予測2016-2027年Global Blood Plasma Fractionation Market Report, History and Forecast 2016-2027 市場の分析と洞察。血漿分画の世界市場 2020年の血漿分画の世界市場規模は2億6384万米ドルで、2021年から2027年の間に7.63%のCAGRで、2027年末には4億3400万米ドルに達すると予測されています。 血漿分画の世... もっと見る
※当ページの内容はウェブ更新時の情報です。
サマリー市場の分析と洞察。血漿分画の世界市場2020年の血漿分画の世界市場規模は2億6384万米ドルで、2021年から2027年の間に7.63%のCAGRで、2027年末には4億3400万米ドルに達すると予測されています。 血漿分画の世界市場範囲と市場規模 血漿分画の世界市場は、地域(国)別、企業別、タイプ別、用途別に分類されています。血液血漿分画の世界市場におけるプレイヤー、ステークホルダー、その他の参加者は、本レポートを強力なリソースとして利用することで、優位に立つことができるでしょう。セグメント別分析では、地域(国)別、タイプ別、アプリケーション別の売上、収益、2016-2027年までの予測に焦点を当てています。 企業別 武田薬品 CSL グリフォルス オクタファーマ ケドリオン LFBグループ ビオテスト BPL RAAS CBPO 花蘭咲バイオ 天壇バイオ 双林バイオ ボヤ・バイオ 遠大首陽 威光バイオ 南越バイオ KM バイオロジクス 種類別セグメント アルブミン 免疫グロブリン 凝固因子 その他 用途別セグメント 病院 小売薬局 その他 地域別 北アメリカ 米国 カナダ メキシコ アジア・パシフィック 中国 日本 韓国 インド オーストラリア 東南アジア 欧州 ドイツ フランス 英国 イタリア ロシア 南米 ブラジル 中東・アフリカ 中東 アフリカ 目次1 BLOOD PLASMA FRACTIONATION MARKET OVERVIEW 11.1 Blood Plasma Fractionation Product Overview 1 1.2 Blood Plasma Fractionation Market Segment by Type 4 1.2.1 Albumin 4 1.2.2 Immune Globulin 5 1.2.3 Coagulation Factor 6 1.3 Global Blood Plasma Fractionation Market Size by Type 7 1.3.1 Global Blood Plasma Fractionation Market Size Overview by Type (2016-2027) 8 1.3.2 Global Blood Plasma Fractionation Historic Market Size Review by Type (2016-2021) 9 1.3.2.1 Global Blood Plasma Fractionation Sales Breakdown in Volume, by Type (2016-2021) 9 1.3.2.2 Global Blood Plasma Fractionation Sales Breakdown in Value, by Type (2016-2021) 10 1.3.2.3 Global Blood Plasma Fractionation Average Selling Price (ASP) by Type (2016-2021) 11 1.3.3 Global Blood Plasma Fractionation Forecasted Market Size by Type (2022-2027) 11 1.3.3.1 Global Blood Plasma Fractionation Sales Breakdown in Volume by Type (2022-2027) 11 1.3.3.2 Global Blood Plasma Fractionation Sales Breakdown in Value by Type (2022-2027) 12 1.3.3.3 Global Blood Plasma Fractionation Average Selling Price (ASP) by Type (2022-2027) 13 1.4 Key Regions Market Size Segment by Type 14 1.4.1 North America Blood Plasma Fractionation Sales Breakdown by Type (2016-2021) 14 1.4.2 Europe Blood Plasma Fractionation Sales Breakdown by Type (2016-2021) 15 1.4.3 Asia-Pacific Blood Plasma Fractionation Sales Breakdown by Type (2016-2021) 17 1.4.4 South America Blood Plasma Fractionation Sales Breakdown by Type (2016-2021) 19 1.4.5 Middle East and Africa Blood Plasma Fractionation Sales Breakdown by Type (2016-2021) 20 2 BLOOD PLASMA FRACTIONATION MARKET COMPETITION BY COMPANY 23 2.1 Global Top Players by Blood Plasma Fractionation Sales (2019-2021) 23 2.2 Global Top Players by Blood Plasma Fractionation Revenue (2019-2021) 24 2.3 Global Top Players by Blood Plasma Fractionation Price (2019-2021) 26 2.4 Global Top Manufacturers Blood Plasma Fractionation Manufacturing Base Distribution, Sales Area, Product Type 27 2.5 Blood Plasma Fractionation Market Competitive Situation and Trends 27 2.5.1 Blood Plasma Fractionation Market Concentration Rate (2019-2021) 27 2.5.2 Global 5 Largest Manufacturers by Blood Plasma Fractionation Sales and Revenue in 2020 28 2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Blood Plasma Fractionation as of 2020) 29 2.7 Founded Date of Key Blood Plasma Fractionation Manufacturers 30 2.8 Key Manufacturers Blood Plasma Fractionation Product Offered 30 2.9 Mergers & Acquisitions, Expansion 31 3 BLOOD PLASMA FRACTIONATION STATUS AND OUTLOOK BY REGION 34 3.1 Global Blood Plasma Fractionation Market Size and CAGR by Region: 2016 VS 2021 VS 2026 34 3.2 Global Blood Plasma Fractionation Historic Market Size by Region 34 3.2.1 Global Blood Plasma Fractionation Sales in Volume by Region (2016-2021) 34 3.2.2 Global Blood Plasma Fractionation Sales in Value by Region (2016-2021) 35 3.2.3 Global Blood Plasma Fractionation Sales (Volume & Value), Price and Gross Margin (2016-2021) 36 3.3 Global Blood Plasma Fractionation Forecasted Market Size by Region 36 3.3.1 Global Blood Plasma Fractionation Sales in Volume by Region (2022-2027) 36 3.3.2 Global Blood Plasma Fractionation Sales in Value by Region (2022-2027) 37 3.3.3 Global Blood Plasma Fractionation Sales (Volume & Value), Price and Gross Margin (2022-2027) 37 4 BLOOD PLASMA FRACTIONATION BY APPLICATION 38 4.1 Blood Plasma Fractionation Market Segment by Application 38 4.1.1 Hospital 38 4.1.2 Retail Pharmacy 39 4.2 Global Blood Plasma Fractionation Market Size by Application 40 4.2.1 Global Blood Plasma Fractionation Market Size Overview by Application (2016-2027) 41 4.2.2 Global Blood Plasma Fractionation Historic Market Size Review by Application (2016-2021) 42 4.2.2.1 Global Blood Plasma Fractionation Sales Breakdown in Volume, by Application (2016-2021) 42 4.2.2.2 Global Blood Plasma Fractionation Sales Breakdown in Value, by Application (2016-2021) 43 4.2.2.3 Global Blood Plasma Fractionation Average Selling Price (ASP) by Application (2016-2021) 44 4.2.3 Global Blood Plasma Fractionation Forecasted Market Size by Application (2022-2027) 45 4.2.3.1 Global Blood Plasma Fractionation Sales Breakdown in Volume by Application (2022-2027) 45 4.2.3.2 Global Blood Plasma Fractionation Sales Breakdown in Value by Application (2022-2027) 46 4.2.3.3 Global Blood Plasma Fractionation Average Selling Price (ASP) by Application (2022-2027) 47 4.3 Key Regions Market Size Segment by Application 48 4.3.1 North America Blood Plasma Fractionation Revenue Breakdown by Application (2016-2021) 48 4.3.2 Europe Blood Plasma Fractionation Revenue Breakdown by Application (2016-2021) 49 4.3.3 Asia-Pacific Blood Plasma Fractionation Revenue Breakdown by Application (2016-2021) 50 4.3.4 South America Blood Plasma Fractionation Revenue Breakdown by Application (2016-2021) 50 4.3.5 Middle East and Africa Blood Plasma Fractionation Revenue Breakdown by Application (2016-2021) 51 5 NORTH AMERICA BLOOD PLASMA FRACTIONATION BY COUNTRY 53 5.1 North America Blood Plasma Fractionation Historic Market Size by Country 53 5.1.1 North America Blood Plasma Fractionation Sales in Volume by Country (2016-2021) 53 5.1.2 North America Blood Plasma Fractionation Sales in Value by Country (2016-2021) 53 5.2 North America Blood Plasma Fractionation Forecasted Market Size by Country 54 5.2.1 North America Blood Plasma Fractionation Sales in Volume by Country (2022-2027) 54 5.2.2 North America Blood Plasma Fractionation Sales in Value by Country (2022-2027) 55 6 EUROPE BLOOD PLASMA FRACTIONATION BY COUNTRY 56 6.1 Europe Blood Plasma Fractionation Historic Market Size by Country 56 6.1.1 Europe Blood Plasma Fractionation Sales in Volume by Country (2016-2021) 56 6.1.2 Europe Blood Plasma Fractionation Sales in Value by Country (2016-2021) 56 6.2 Europe Blood Plasma Fractionation Forecasted Market Size by Country 57 6.2.1 Europe Blood Plasma Fractionation Sales in Volume by Country (2022-2027) 57 6.2.2 Europe Blood Plasma Fractionation Sales in Value by Country (2022-2027) 58 7 ASIA-PACIFIC BLOOD PLASMA FRACTIONATION BY REGION 59 7.1 Asia-Pacific Blood Plasma Fractionation Historic Market Size by Region 59 7.1.1 Asia-Pacific Blood Plasma Fractionation Sales in Volume by Region (2016-2021) 59 7.1.2 Asia-Pacific Blood Plasma Fractionation Sales in Value by Region (2016-2021) 60 7.2 Asia-Pacific Blood Plasma Fractionation Forecasted Market Size by Region 61 7.2.1 Asia-Pacific Blood Plasma Fractionation Sales in Volume by Region (2022-2027) 61 7.2.2 Asia-Pacific Blood Plasma Fractionation Sales in Value by Region (2022-2027) 62 8 SOUTH AMERICA BLOOD PLASMA FRACTIONATION BY COUNTRY 63 8.1 South America Blood Plasma Fractionation Historic Market Size by Country 63 8.1.1 South America Blood Plasma Fractionation Sales in Volume by Country (2016-2021) 63 8.1.2 South America Blood Plasma Fractionation Sales in Value by Country (2016-2021) 63 8.2 South America Blood Plasma Fractionation Forecasted Market Size by Country 64 8.2.1 South America Blood Plasma Fractionation Sales in Volume by Country (2022-2027) 64 8.2.2 South America Blood Plasma Fractionation Sales in Value by Country (2022-2027) 65 9 MIDDLE EAST AND AFRICA BLOOD PLASMA FRACTIONATION BY COUNTRY 66 9.1 Middle East and Africa Blood Plasma Fractionation Historic Market Size by Country 66 9.1.1 Middle East and Africa Blood Plasma Fractionation Sales in Volume by Country (2016-2021) 66 9.1.2 Middle East and Africa Blood Plasma Fractionation Sales in Value by Country (2016-2021) 66 9.2 Middle East and Africa Blood Plasma Fractionation Forecasted Market Size by Country 67 9.2.1 Middle East and Africa Blood Plasma Fractionation Sales in Volume by Country (2022-2027) 67 9.2.2 Middle East and Africa Blood Plasma Fractionation Sales in Value by Country (2022-2027) 68 10 COMPANY PROFILES AND KEY FIGURES IN BLOOD PLASMA FRACTIONATION BUSINESS 69 10.1 Takeda 69 10.1.1 Takeda Company Information 69 10.1.2 Takeda Blood Plasma Fractionation Product Offered 70 10.1.3 Takeda Blood Plasma Fractionation Sales, Revenue and Gross Margin (2019-2021) 71 10.1.4 Takeda Main Business Overview 71 10.1.5 Takeda Latest Developments 71 10.2 CSL 73 10.2.1 CSL Company Information 73 10.2.2 CSL Blood Plasma Fractionation Product Offered 74 10.2.3 CSL Blood Plasma Fractionation Sales, Revenue and Gross Margin (2019-2021) 75 10.2.4 CSL Main Business Overview 75 10.2.5 CSL Latest Developments 75 10.3 Grifols 76 10.3.1 Grifols Company Information 76 10.3.2 Grifols Blood Plasma Fractionation Product Offered 77 10.3.3 Grifols Blood Plasma Fractionation Sales, Revenue and Gross Margin (2019-2021) 79 10.3.4 Grifols Main Business Overview 79 10.3.5 Grifols Latest Developments 79 10.4 Octapharma 80 10.4.1 Octapharma Company Information 80 10.4.2 Octapharma Blood Plasma Fractionation Product Offered 81 10.4.3 Octapharma Blood Plasma Fractionation Sales, Revenue and Gross Margin (2019-2021) 82 10.4.4 Octapharma Main Business Overview 82 10.4.5 Octapharma Latest Developments 82 10.5 Kedrion 83 10.5.1 Kedrion Company Information 83 10.5.2 Kedrion Blood Plasma Fractionation Product Offered 83 10.5.3 Kedrion Blood Plasma Fractionation Sales, Revenue and Gross Margin (2019-2021) 84 10.5.4 Kedrion Main Business Overview 85 10.6 LFB Group 85 10.6.1 LFB Group Company Information 85 10.6.2 LFB Group Blood Plasma Fractionation Product Offered 86 10.6.3 LFB Group Blood Plasma Fractionation Sales, Revenue and Gross Margin (2019-2021) 86 10.6.4 LFB Group Main Business Overview 86 10.7 Biotest 87 10.7.1 Biotest Company Information 87 10.7.2 Biotest Blood Plasma Fractionation Product Offered 88 10.7.3 Biotest Blood Plasma Fractionation Sales, Revenue and Gross Margin (2019-2021) 88 10.7.4 Biotest Main Business Overview 88 10.8 BPL 89 10.8.1 BPL Company Information 89 10.8.2 BPL Blood Plasma Fractionation Product Offered 89 10.8.3 BPL Blood Plasma Fractionation Sales, Revenue and Gross Margin (2019-2021) 90 10.8.4 BPL Main Business Overview 90 10.8.5 BPL Latest Developments 91 10.9 RAAS 92 10.9.1 RAAS Company Information 92 10.9.2 RAAS Blood Plasma Fractionation Product Offered 92 10.9.3 RAAS Blood Plasma Fractionation Sales, Revenue and Gross Margin (2019-2021) 94 10.9.4 RAAS Main Business Overview 94 10.9.5 RAAS Latest Developments 95 10.10 CBPO 96 10.10.1 CBPO Company Information 96 10.10.2 CBPO Blood Plasma Fractionation Product Offered 97 10.10.3 CBPO Blood Plasma Fractionation Sales, Revenue and Gross Margin (2019-2021) 97 10.10.4 CBPO Main Business Overview 97 10.10.5 CBPO Latest Developments 97 10.11 Hualan Bio 99 10.11.1 Hualan Bio Company Information 99 10.11.2 Hualan Bio Blood Plasma Fractionation Product Offered 99 10.11.3 Hualan Bio Blood Plasma Fractionation Sales, Revenue and Gross Margin (2019-2021) 101 10.11.4 Hualan Bio Main Business Overview 101 10.12 Tiantan Bio 102 10.12.1 Tiantan Bio Corporation Information 102 10.12.2 Tiantan Bio Blood Plasma Fractionation Products Offered 103 10.12.3 Tiantan Bio Blood Plasma Fractionation Sales, Revenue and Gross Margin (2019-2021) 103 10.12.4 Tiantan Bio Main Business Overview 104 10.13 Shuanglin Bio 104 10.13.1 Shuanglin Bio Corporation Information 104 10.13.2 Shuanglin Bio Blood Plasma Fractionation Products Offered 105 10.13.3 Shuanglin Bio Blood Plasma Fractionation Sales, Revenue and Gross Margin (2019-2021) 105 10.13.4 Shuanglin Bio Main Business Overview 106 10.14 Boya Bio 106 10.14.1 Boya Bio Corporation Information 106 10.14.2 Boya Bio Blood Plasma Fractionation Products Offered 107 10.14.3 Boya Bio Blood Plasma Fractionation Sales, Revenue and Gross Margin (2019-2021) 108 10.14.4 Boya Bio Main Business Overview 108 10.15 Yuanda Shuyang 109 10.15.1 Yuanda Shuyang Corporation Information 109 10.15.2 Yuanda Shuyang Blood Plasma Fractionation Products Offered 109 10.15.3 Yuanda Shuyang Blood Plasma Fractionation Sales, Revenue and Gross Margin (2019-2021) 110 10.15.4 Yuanda Shuyang Main Business Overview 111 10.16 Weiguang Bio 111 10.16.1 Weiguang Bio Corporation Information 111 10.16.2 Weiguang Bio Blood Plasma Fractionation Products Offered 112 10.16.3 Weiguang Bio Blood Plasma Fractionation Sales, Revenue and Gross Margin (2019-2021) 113 10.16.4 Weiguang Bio Main Business Overview 113 10.17 Nanyue Bio 114 10.17.1 Nanyue Bio Corporation Information 114 10.17.2 Nanyue Bio Blood Plasma Fractionation Products Offered 114 10.17.3 Nanyue Bio Blood Plasma Fractionation Sales, Revenue and Gross Margin (2019-2021) 115 10.17.4 Nanyue Bio Main Business Overview 116 10.18 KM Biologics 116 10.18.1 KM Biologics Corporation Information 116 10.18.2 KM Biologics Blood Plasma Fractionation Products Offered 117 10.18.3 KM Biologics Blood Plasma Fractionation Sales, Revenue and Gross Margin (2019-2021) 119 10.18.4 KM Biologics Main Business Overview 120 10.18.5 KM Biologics Recent Development 120 11 UPSTREAM, OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS 122 11.1 Blood Plasma Fractionation Key Raw Materials 122 11.1.1 Key Raw Materials 122 11.1.2 Raw Materials Key Suppliers 124 11.2 Manufacturing Cost Structure 125 11.2.1 Raw Materials 125 11.2.2 Labor Cost 125 11.2.3 Manufacturing Expenses 126 11.3 Manufacturing Process Analysis of Blood Plasma Fractionation 126 11.4 Blood Plasma Fractionation Industrial Chain Analysis 128 11.5 Blood Plasma Fractionation Market Dynamics 129 11.5.1 Industry Trends 129 11.5.2 Market Drivers 130 11.5.3 Market Challenges 131 11.5.4 Market Restraints 131 12 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS 132 12.1 Sales Channel 132 12.2 Blood Plasma Fractionation Distributors 133 12.3 Blood Plasma Fractionation Downstream Customers 136 13 RESEARCH FINDINGS AND CONCLUSION 139 14 APPENDIX 141 14.1 Research Methodology 141 14.1.1 Methodology/Research Approach 141 14.1.1.1 Research Programs/Design 141 14.1.1.2 Market Size Estimation 142 14.1.1.3 Market Breakdown and Data Triangulation 143 14.1.2 Data Source 144 14.1.2.1 Secondary Sources 144 14.1.2.2 Primary Sources 145 14.2 Author Details 147 14.3 Disclaimer 148
SummaryMarket Analysis and Insights: Global Blood Plasma Fractionation Market Table of Contents1 BLOOD PLASMA FRACTIONATION MARKET OVERVIEW 11.1 Blood Plasma Fractionation Product Overview 1 1.2 Blood Plasma Fractionation Market Segment by Type 4 1.2.1 Albumin 4 1.2.2 Immune Globulin 5 1.2.3 Coagulation Factor 6 1.3 Global Blood Plasma Fractionation Market Size by Type 7 1.3.1 Global Blood Plasma Fractionation Market Size Overview by Type (2016-2027) 8 1.3.2 Global Blood Plasma Fractionation Historic Market Size Review by Type (2016-2021) 9 1.3.2.1 Global Blood Plasma Fractionation Sales Breakdown in Volume, by Type (2016-2021) 9 1.3.2.2 Global Blood Plasma Fractionation Sales Breakdown in Value, by Type (2016-2021) 10 1.3.2.3 Global Blood Plasma Fractionation Average Selling Price (ASP) by Type (2016-2021) 11 1.3.3 Global Blood Plasma Fractionation Forecasted Market Size by Type (2022-2027) 11 1.3.3.1 Global Blood Plasma Fractionation Sales Breakdown in Volume by Type (2022-2027) 11 1.3.3.2 Global Blood Plasma Fractionation Sales Breakdown in Value by Type (2022-2027) 12 1.3.3.3 Global Blood Plasma Fractionation Average Selling Price (ASP) by Type (2022-2027) 13 1.4 Key Regions Market Size Segment by Type 14 1.4.1 North America Blood Plasma Fractionation Sales Breakdown by Type (2016-2021) 14 1.4.2 Europe Blood Plasma Fractionation Sales Breakdown by Type (2016-2021) 15 1.4.3 Asia-Pacific Blood Plasma Fractionation Sales Breakdown by Type (2016-2021) 17 1.4.4 South America Blood Plasma Fractionation Sales Breakdown by Type (2016-2021) 19 1.4.5 Middle East and Africa Blood Plasma Fractionation Sales Breakdown by Type (2016-2021) 20 2 BLOOD PLASMA FRACTIONATION MARKET COMPETITION BY COMPANY 23 2.1 Global Top Players by Blood Plasma Fractionation Sales (2019-2021) 23 2.2 Global Top Players by Blood Plasma Fractionation Revenue (2019-2021) 24 2.3 Global Top Players by Blood Plasma Fractionation Price (2019-2021) 26 2.4 Global Top Manufacturers Blood Plasma Fractionation Manufacturing Base Distribution, Sales Area, Product Type 27 2.5 Blood Plasma Fractionation Market Competitive Situation and Trends 27 2.5.1 Blood Plasma Fractionation Market Concentration Rate (2019-2021) 27 2.5.2 Global 5 Largest Manufacturers by Blood Plasma Fractionation Sales and Revenue in 2020 28 2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Blood Plasma Fractionation as of 2020) 29 2.7 Founded Date of Key Blood Plasma Fractionation Manufacturers 30 2.8 Key Manufacturers Blood Plasma Fractionation Product Offered 30 2.9 Mergers & Acquisitions, Expansion 31 3 BLOOD PLASMA FRACTIONATION STATUS AND OUTLOOK BY REGION 34 3.1 Global Blood Plasma Fractionation Market Size and CAGR by Region: 2016 VS 2021 VS 2026 34 3.2 Global Blood Plasma Fractionation Historic Market Size by Region 34 3.2.1 Global Blood Plasma Fractionation Sales in Volume by Region (2016-2021) 34 3.2.2 Global Blood Plasma Fractionation Sales in Value by Region (2016-2021) 35 3.2.3 Global Blood Plasma Fractionation Sales (Volume & Value), Price and Gross Margin (2016-2021) 36 3.3 Global Blood Plasma Fractionation Forecasted Market Size by Region 36 3.3.1 Global Blood Plasma Fractionation Sales in Volume by Region (2022-2027) 36 3.3.2 Global Blood Plasma Fractionation Sales in Value by Region (2022-2027) 37 3.3.3 Global Blood Plasma Fractionation Sales (Volume & Value), Price and Gross Margin (2022-2027) 37 4 BLOOD PLASMA FRACTIONATION BY APPLICATION 38 4.1 Blood Plasma Fractionation Market Segment by Application 38 4.1.1 Hospital 38 4.1.2 Retail Pharmacy 39 4.2 Global Blood Plasma Fractionation Market Size by Application 40 4.2.1 Global Blood Plasma Fractionation Market Size Overview by Application (2016-2027) 41 4.2.2 Global Blood Plasma Fractionation Historic Market Size Review by Application (2016-2021) 42 4.2.2.1 Global Blood Plasma Fractionation Sales Breakdown in Volume, by Application (2016-2021) 42 4.2.2.2 Global Blood Plasma Fractionation Sales Breakdown in Value, by Application (2016-2021) 43 4.2.2.3 Global Blood Plasma Fractionation Average Selling Price (ASP) by Application (2016-2021) 44 4.2.3 Global Blood Plasma Fractionation Forecasted Market Size by Application (2022-2027) 45 4.2.3.1 Global Blood Plasma Fractionation Sales Breakdown in Volume by Application (2022-2027) 45 4.2.3.2 Global Blood Plasma Fractionation Sales Breakdown in Value by Application (2022-2027) 46 4.2.3.3 Global Blood Plasma Fractionation Average Selling Price (ASP) by Application (2022-2027) 47 4.3 Key Regions Market Size Segment by Application 48 4.3.1 North America Blood Plasma Fractionation Revenue Breakdown by Application (2016-2021) 48 4.3.2 Europe Blood Plasma Fractionation Revenue Breakdown by Application (2016-2021) 49 4.3.3 Asia-Pacific Blood Plasma Fractionation Revenue Breakdown by Application (2016-2021) 50 4.3.4 South America Blood Plasma Fractionation Revenue Breakdown by Application (2016-2021) 50 4.3.5 Middle East and Africa Blood Plasma Fractionation Revenue Breakdown by Application (2016-2021) 51 5 NORTH AMERICA BLOOD PLASMA FRACTIONATION BY COUNTRY 53 5.1 North America Blood Plasma Fractionation Historic Market Size by Country 53 5.1.1 North America Blood Plasma Fractionation Sales in Volume by Country (2016-2021) 53 5.1.2 North America Blood Plasma Fractionation Sales in Value by Country (2016-2021) 53 5.2 North America Blood Plasma Fractionation Forecasted Market Size by Country 54 5.2.1 North America Blood Plasma Fractionation Sales in Volume by Country (2022-2027) 54 5.2.2 North America Blood Plasma Fractionation Sales in Value by Country (2022-2027) 55 6 EUROPE BLOOD PLASMA FRACTIONATION BY COUNTRY 56 6.1 Europe Blood Plasma Fractionation Historic Market Size by Country 56 6.1.1 Europe Blood Plasma Fractionation Sales in Volume by Country (2016-2021) 56 6.1.2 Europe Blood Plasma Fractionation Sales in Value by Country (2016-2021) 56 6.2 Europe Blood Plasma Fractionation Forecasted Market Size by Country 57 6.2.1 Europe Blood Plasma Fractionation Sales in Volume by Country (2022-2027) 57 6.2.2 Europe Blood Plasma Fractionation Sales in Value by Country (2022-2027) 58 7 ASIA-PACIFIC BLOOD PLASMA FRACTIONATION BY REGION 59 7.1 Asia-Pacific Blood Plasma Fractionation Historic Market Size by Region 59 7.1.1 Asia-Pacific Blood Plasma Fractionation Sales in Volume by Region (2016-2021) 59 7.1.2 Asia-Pacific Blood Plasma Fractionation Sales in Value by Region (2016-2021) 60 7.2 Asia-Pacific Blood Plasma Fractionation Forecasted Market Size by Region 61 7.2.1 Asia-Pacific Blood Plasma Fractionation Sales in Volume by Region (2022-2027) 61 7.2.2 Asia-Pacific Blood Plasma Fractionation Sales in Value by Region (2022-2027) 62 8 SOUTH AMERICA BLOOD PLASMA FRACTIONATION BY COUNTRY 63 8.1 South America Blood Plasma Fractionation Historic Market Size by Country 63 8.1.1 South America Blood Plasma Fractionation Sales in Volume by Country (2016-2021) 63 8.1.2 South America Blood Plasma Fractionation Sales in Value by Country (2016-2021) 63 8.2 South America Blood Plasma Fractionation Forecasted Market Size by Country 64 8.2.1 South America Blood Plasma Fractionation Sales in Volume by Country (2022-2027) 64 8.2.2 South America Blood Plasma Fractionation Sales in Value by Country (2022-2027) 65 9 MIDDLE EAST AND AFRICA BLOOD PLASMA FRACTIONATION BY COUNTRY 66 9.1 Middle East and Africa Blood Plasma Fractionation Historic Market Size by Country 66 9.1.1 Middle East and Africa Blood Plasma Fractionation Sales in Volume by Country (2016-2021) 66 9.1.2 Middle East and Africa Blood Plasma Fractionation Sales in Value by Country (2016-2021) 66 9.2 Middle East and Africa Blood Plasma Fractionation Forecasted Market Size by Country 67 9.2.1 Middle East and Africa Blood Plasma Fractionation Sales in Volume by Country (2022-2027) 67 9.2.2 Middle East and Africa Blood Plasma Fractionation Sales in Value by Country (2022-2027) 68 10 COMPANY PROFILES AND KEY FIGURES IN BLOOD PLASMA FRACTIONATION BUSINESS 69 10.1 Takeda 69 10.1.1 Takeda Company Information 69 10.1.2 Takeda Blood Plasma Fractionation Product Offered 70 10.1.3 Takeda Blood Plasma Fractionation Sales, Revenue and Gross Margin (2019-2021) 71 10.1.4 Takeda Main Business Overview 71 10.1.5 Takeda Latest Developments 71 10.2 CSL 73 10.2.1 CSL Company Information 73 10.2.2 CSL Blood Plasma Fractionation Product Offered 74 10.2.3 CSL Blood Plasma Fractionation Sales, Revenue and Gross Margin (2019-2021) 75 10.2.4 CSL Main Business Overview 75 10.2.5 CSL Latest Developments 75 10.3 Grifols 76 10.3.1 Grifols Company Information 76 10.3.2 Grifols Blood Plasma Fractionation Product Offered 77 10.3.3 Grifols Blood Plasma Fractionation Sales, Revenue and Gross Margin (2019-2021) 79 10.3.4 Grifols Main Business Overview 79 10.3.5 Grifols Latest Developments 79 10.4 Octapharma 80 10.4.1 Octapharma Company Information 80 10.4.2 Octapharma Blood Plasma Fractionation Product Offered 81 10.4.3 Octapharma Blood Plasma Fractionation Sales, Revenue and Gross Margin (2019-2021) 82 10.4.4 Octapharma Main Business Overview 82 10.4.5 Octapharma Latest Developments 82 10.5 Kedrion 83 10.5.1 Kedrion Company Information 83 10.5.2 Kedrion Blood Plasma Fractionation Product Offered 83 10.5.3 Kedrion Blood Plasma Fractionation Sales, Revenue and Gross Margin (2019-2021) 84 10.5.4 Kedrion Main Business Overview 85 10.6 LFB Group 85 10.6.1 LFB Group Company Information 85 10.6.2 LFB Group Blood Plasma Fractionation Product Offered 86 10.6.3 LFB Group Blood Plasma Fractionation Sales, Revenue and Gross Margin (2019-2021) 86 10.6.4 LFB Group Main Business Overview 86 10.7 Biotest 87 10.7.1 Biotest Company Information 87 10.7.2 Biotest Blood Plasma Fractionation Product Offered 88 10.7.3 Biotest Blood Plasma Fractionation Sales, Revenue and Gross Margin (2019-2021) 88 10.7.4 Biotest Main Business Overview 88 10.8 BPL 89 10.8.1 BPL Company Information 89 10.8.2 BPL Blood Plasma Fractionation Product Offered 89 10.8.3 BPL Blood Plasma Fractionation Sales, Revenue and Gross Margin (2019-2021) 90 10.8.4 BPL Main Business Overview 90 10.8.5 BPL Latest Developments 91 10.9 RAAS 92 10.9.1 RAAS Company Information 92 10.9.2 RAAS Blood Plasma Fractionation Product Offered 92 10.9.3 RAAS Blood Plasma Fractionation Sales, Revenue and Gross Margin (2019-2021) 94 10.9.4 RAAS Main Business Overview 94 10.9.5 RAAS Latest Developments 95 10.10 CBPO 96 10.10.1 CBPO Company Information 96 10.10.2 CBPO Blood Plasma Fractionation Product Offered 97 10.10.3 CBPO Blood Plasma Fractionation Sales, Revenue and Gross Margin (2019-2021) 97 10.10.4 CBPO Main Business Overview 97 10.10.5 CBPO Latest Developments 97 10.11 Hualan Bio 99 10.11.1 Hualan Bio Company Information 99 10.11.2 Hualan Bio Blood Plasma Fractionation Product Offered 99 10.11.3 Hualan Bio Blood Plasma Fractionation Sales, Revenue and Gross Margin (2019-2021) 101 10.11.4 Hualan Bio Main Business Overview 101 10.12 Tiantan Bio 102 10.12.1 Tiantan Bio Corporation Information 102 10.12.2 Tiantan Bio Blood Plasma Fractionation Products Offered 103 10.12.3 Tiantan Bio Blood Plasma Fractionation Sales, Revenue and Gross Margin (2019-2021) 103 10.12.4 Tiantan Bio Main Business Overview 104 10.13 Shuanglin Bio 104 10.13.1 Shuanglin Bio Corporation Information 104 10.13.2 Shuanglin Bio Blood Plasma Fractionation Products Offered 105 10.13.3 Shuanglin Bio Blood Plasma Fractionation Sales, Revenue and Gross Margin (2019-2021) 105 10.13.4 Shuanglin Bio Main Business Overview 106 10.14 Boya Bio 106 10.14.1 Boya Bio Corporation Information 106 10.14.2 Boya Bio Blood Plasma Fractionation Products Offered 107 10.14.3 Boya Bio Blood Plasma Fractionation Sales, Revenue and Gross Margin (2019-2021) 108 10.14.4 Boya Bio Main Business Overview 108 10.15 Yuanda Shuyang 109 10.15.1 Yuanda Shuyang Corporation Information 109 10.15.2 Yuanda Shuyang Blood Plasma Fractionation Products Offered 109 10.15.3 Yuanda Shuyang Blood Plasma Fractionation Sales, Revenue and Gross Margin (2019-2021) 110 10.15.4 Yuanda Shuyang Main Business Overview 111 10.16 Weiguang Bio 111 10.16.1 Weiguang Bio Corporation Information 111 10.16.2 Weiguang Bio Blood Plasma Fractionation Products Offered 112 10.16.3 Weiguang Bio Blood Plasma Fractionation Sales, Revenue and Gross Margin (2019-2021) 113 10.16.4 Weiguang Bio Main Business Overview 113 10.17 Nanyue Bio 114 10.17.1 Nanyue Bio Corporation Information 114 10.17.2 Nanyue Bio Blood Plasma Fractionation Products Offered 114 10.17.3 Nanyue Bio Blood Plasma Fractionation Sales, Revenue and Gross Margin (2019-2021) 115 10.17.4 Nanyue Bio Main Business Overview 116 10.18 KM Biologics 116 10.18.1 KM Biologics Corporation Information 116 10.18.2 KM Biologics Blood Plasma Fractionation Products Offered 117 10.18.3 KM Biologics Blood Plasma Fractionation Sales, Revenue and Gross Margin (2019-2021) 119 10.18.4 KM Biologics Main Business Overview 120 10.18.5 KM Biologics Recent Development 120 11 UPSTREAM, OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS 122 11.1 Blood Plasma Fractionation Key Raw Materials 122 11.1.1 Key Raw Materials 122 11.1.2 Raw Materials Key Suppliers 124 11.2 Manufacturing Cost Structure 125 11.2.1 Raw Materials 125 11.2.2 Labor Cost 125 11.2.3 Manufacturing Expenses 126 11.3 Manufacturing Process Analysis of Blood Plasma Fractionation 126 11.4 Blood Plasma Fractionation Industrial Chain Analysis 128 11.5 Blood Plasma Fractionation Market Dynamics 129 11.5.1 Industry Trends 129 11.5.2 Market Drivers 130 11.5.3 Market Challenges 131 11.5.4 Market Restraints 131 12 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS 132 12.1 Sales Channel 132 12.2 Blood Plasma Fractionation Distributors 133 12.3 Blood Plasma Fractionation Downstream Customers 136 13 RESEARCH FINDINGS AND CONCLUSION 139 14 APPENDIX 141 14.1 Research Methodology 141 14.1.1 Methodology/Research Approach 141 14.1.1.1 Research Programs/Design 141 14.1.1.2 Market Size Estimation 142 14.1.1.3 Market Breakdown and Data Triangulation 143 14.1.2 Data Source 144 14.1.2.1 Secondary Sources 144 14.1.2.2 Primary Sources 145 14.2 Author Details 147 14.3 Disclaimer 148
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(その他)の最新刊レポートQYResearch 社の最新刊レポート本レポートと同じKEY WORD(plasma)の最新刊レポート
よくあるご質問QYResearch社はどのような調査会社ですか?QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。 QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/09/09 10:27 143.78 円 159.73 円 191.51 円 |